Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.

Yu-ping Zhong; Yi-zhuo Zhang; Ai-jun Liao; Su-xia LI; Chen Tian; Jin LU

Return

Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.

Author: Yu-Ping ZHONG ¹ ; Yi-Zhuo ZHANG ² ; Ai-Jun LIAO ³ ; Su-Xia LI ⁴ ; Chen TIAN ⁵ ; Jin LU ⁶
Author Information

1. Department of Hematology, Beijing Chaoyang Hospital (West), Capital Medical University, Beijing University Clinical Research Institute, Beijing 100043, China.
2. Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Cancer Hospital, Tianjin 300000, China.
3. Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
4. Department of Hematology, The People's Liberation Army 301 Hospital, Beijing 100853, China.
5. Department of Hematology, The People's Liberation Army 304 Hospital, Beijing 100048, China.
6. Department of Hematology, Peking University People's Hospital and Peking University Institute of Hematology, Beijing 100044, China.
Publication Type:Journal Article
MeSH: Activities of Daily Living; Aged; China; Cognition; physiology; Female; Geriatric Assessment; methods; Humans; Kaplan-Meier Estimate; Male; Multiple Myeloma; mortality; physiopathology; psychology; Retrospective Studies
From: Chinese Medical Journal 2017;130(2):130-134
CountryChina
Language:English
Abstract:
BACKGROUNDElderly multiple myeloma (MM) patients often tend to suffer a variety of diseases, so the treatment of choice is very difficult for the elderly myeloma patients. The overall survival (OS) time and side effects with elderly patients are unclear in China. The study tried to find out the role of geriatric assessment in the Chinese elderly MM.
METHODSWe retrospectively analyzed the data of 628 newly diagnosed patients from six hospitals from June 2011 to June 2013. A geriatric assessment had been performed to assess comorbidities, cognitive, and physical status for these patients. The primary endpoint was to evaluate different physical states of elderly patients with OS time and treatment-related side effects.
RESULTSAn additive scoring system (range: 0-5), based on age, Katz's Activity of Daily Living (ADL) and Lawton's Instrumental Activity of Daily Living (IADL) ≤5 and Charlson Comorbidity Index (CCI) was developed to identify three groups: fit (score = 0); intermediate-fitness (score = 1); and frail (score ≥2). The 3-year OS was 63% in fit patients, 63% in intermediate-fitness patients, and 49% in frail patients ≥3 hematologic adverse events (AEs) were documented in 45 (35.4%) fit, 34 (34%) intermediate-fitness, and 121 (30.2%) frail patients. The risk of a grade ≥3 hematologic AEs was not significantly increase in intermediate-fitness (hazard ratios [HR]: 0.99, 95% confidence interval [CI]: 0.54-1.47, P = 1.000) and in frail patients (HR: 1.16, 95% CI: 0.70-1.93, P = 0.558) compared with fit ones.
CONCLUSIONSMM occurs earlier in life and being advanced when the diagnosis is made in the mainland of China. The overall survival in frailty with International Staging System (ISS) II/III was the worst in all patients.